Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 868 participants.
Also called NCT07519044
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 868 participants
- Sponsor
- Registry
-
NCT07519044
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07519044. Randomized; double masking; primary purpose treatment. Start 2026-05-14 (actual); primary completion 2027-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
- Acronym
- IAT-GIANT
- Condition
- Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous GM1 Therapy
- Intervention (Drug)
- Placebo Therapy
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct07519044- Content hash
03fb65fca526a4273084fa05701cecfe051af2870bbee6d00d85eeef105963d2